Skip to content

Aldeyra Therapeutics, Inc.

ALDX· NasdaqCore metricsCIK 1341235

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -3.04%
Market cap
$37.73M
60.36M shares
Filings
654
—
—
—
-$3.76M
Q3 2026N/M FY25 yoy
-$4.14M
Q3 2026N/M FY25 yoy
-$30.33M
FY 2023derivedN/M FY23 yoy
-$0.06
Q3 2026N/M FY25 yoy
$40.97M
Q3 2026+28.5% FY25 yoy
$37.73M
—
—
1.1×
—
—

FY2025 figures · derived

Price

$0.625188.02%$4.5949past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$25.66MFY 2025
$48.22M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$25,662,855reported
FY 20242024-12-31$48,224,793reported
FY 20232023-12-31$29,458,719reported
FY 20222022-12-31$47,306,066reported
FY 20212021-12-31$44,936,532reported
FY 20202020-12-31$24,681,301reported
FY 20192019-12-31$44,351,851reported
FY 20182018-12-31$29,823,007reported
FY 20172017-12-31$16,302,568reported
FY 20162016-12-31$13,175,670reported
FY 20152015-12-31$7,574,398reported
FY 20142014-12-31$3,707,544reported

Pharmaceutical preparations

Aldeyra Therapeutics, Inc. is the 348th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Aldeyra Therapeutics, Inc. · CIK 1341235 · Engraved from SEC EDGAR